LEADER 02629nam 2200841z- 450 001 9911053096803321 005 20230911 035 $a(CKB)5690000000228493 035 $a(oapen)doab113982 035 $a(EXLCZ)995690000000228493 100 $a20230920c2023uuuu -u- - 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aAdipose Tissue Inflammation 2022 210 $cMDPI - Multidisciplinary Digital Publishing Institute$d2023 215 $a1 online resource (168 p.) 311 08$a3-0365-8674-1 330 $aThis reprint presents recent advances in understanding the molecular processes that take place in adipose tissue inflammation in the context of obesity. It discusses the impact of adipose tissue inflammation on systemic metabolic alterations associated with excess adiposity, as well as its repercussion in several pathological conditions that may help to understand obesity-associated metabolic derangements. 606 $aMedicine$2bicssc 610 $aadipogenesis 610 $aadipokines 610 $aadiponectin 610 $aadipose tissue 610 $aadipose tissue inflammation 610 $aarterial thrombosis 610 $abariatric surgery 610 $aBDNF 610 $abody fat distribution 610 $abody mass index 610 $acoagulopathy 610 $acolostrum 610 $aCOVID-19 610 $acytokine storm 610 $afatty acid-binding protein 4 610 $agestational diabetes mellitus 610 $ahypoxia 610 $aIl-6 610 $ainflammation 610 $ainsulin resistance 610 $aIRFs 610 $aleptin 610 $alipectomy 610 $aliver 610 $aliver resection 610 $aliver transplantation 610 $amast cells 610 $aMcp-1 610 $an/a 610 $aobesity 610 $aobesity pathophysiology 610 $aoverweight 610 $aoxidative stress 610 $apancreatic ductal adenocarcinoma 610 $aphagocytes 610 $aphysical exercise 610 $aproinflammatory adipokine 610 $aSARS-CoV-2 610 $asteatosis 610 $asteroid receptor RNA activator 1/SRA1 610 $aTLRs 610 $aTnf-? 610 $atype 2 diabetes 610 $atype 2 diabetes mellitus 610 $atype-2 diabetes 610 $aVal66Met polymorphism 615 7$aMedicine 906 $aBOOK 912 $a9911053096803321 996 $aAdipose Tissue Inflammation 2022$94524716 997 $aUNINA